[EFFECT] Terns Pharmaceuticals, Inc. SEC Filing Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type EFFECT 05/08/2026 - 12:15 AM ⛶ Fullscreen UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: May 7, 2026 Accession Number: 0001193125-26-205352 Submission Type: POS AM CIK: 0001831363 Company Name: Terns Pharmaceuticals, Inc. File Number: 333-287092 Source: View Original Filing on SEC EDGAR
